Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Clinical trial NCT06225622 · UNKNOWN
Trial details
- NCT number
- NCT06225622
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2026-01-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.